Mealey's (November 18, 2021, 1:18 PM EST) -- KANSAS CITY, Kan. — The judge overseeing the EpiPen multidistrict litigation on Nov. 17 granted final approval to Pfizer Inc.’s $345 million consumer and third-party payer class settlement, along with $115 million in attorney fees, $3.23 million in costs and class representative awards of up to $5,000 for 35 persons....